ABBV or EFX: which has stronger momentum now?
As of 2026-09-01: ABBV LONG (67 bars, uPnL +20.3%, total return +25.0%) vs EFX LONG (28 bars, uPnL +5.7%, total return -45.1%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| ABBV (AbbVie) | EFX (Equifax) | |
| Market / sector | us · Healthcare | us · Industrials |
| Price | $258.15 | $190.36 |
| Quality score | 100/100 | 100/100 |
| Engine signal | LONG · 67 bars · uPnL +20.3% | LONG · 28 bars · uPnL +5.7% |
| Total return | +25.0% | -45.1% |
Cite this page
Balance Labs Research Desk (2026-09-01). "ABBV or EFX: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/abbv-vs-efx/q/abbv-or-efx-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← ABBV vs EFX · snapshot 2026-09-01 · not investment advice